# Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers

> **NCT03671941** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 31 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** D578
- **DRUG:** CKD-357

## Key facts

- **NCT ID:** NCT03671941
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-25
- **Primary completion:** 2018-06-04
- **Final completion:** 2018-06-18
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03671941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03671941, "Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03671941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*